INCY · Q1 FY26 · Jan 1 – Mar 31, 2026
Incyte Q1 FY26: where the revenue came from and where it went
Incyte Q1 FY26: revenue $1.3B (+21% year over year). Net profit $0.3B. Largest cohort JAKAFI $0.8B. The whole income statement as a sankey diagram from the SEC filing.
- Period
- Jan 1 – Mar 31, 2026
- Reported
- Jul 28, 2026
Tap the diagram to enlarge · figures in billions of dollars
Revenue$1.3B
+21% year over year
Gross profit$1.2B
92% margin
Operating profit$0.3B
24% margin
Net profit$0.3B
24% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 1.3 | 100% | +21% |
| JAKAFI | 0.8 | 62% | |
| Product royalty revenues | 0.2 | 15% | +34% |
| NIKTIMVO | 0.1 | 8% | |
| MINJUVI/MONJUVI | 0.1 | 8% | |
| Cost of revenue | −0.1 | 8% | |
| Gross profit | 1.2 | 92% margin | −1pp |
| Research & development | −0.5 | 41% | −1pp |
| SG&A | −0.3 | 26% | −5pp |
| Operating profit | 0.3 | 24% margin | +4pp |
| Net profit | 0.3 | 24% | +9pp |
Older quarters
New results in your inbox
When a big company reports, you get the diagram before anyone has time to comment on it. No spam, one-click unsubscribe.